ERBB2 and breast carcinoma: Collectively, these data suggested that the expression of miR-125a, miR-125b, and/or miR-205 could be specifically increased in breast cancer cells; and two miRNAs, especially miR-125a and miR-205 showed functional cooperation to suppress erbB3 expression in HER2-overexpressing breast cancer cells.